Saint Luke's Newsroom
May. 21, 2021

KMBC: New drug shows promise for patients with common genetic heart condition
KMBC talked to Dr. John Spertus about the exciting results of the EXPLORER-HCM Trial and one participant who says it changed his life.
May. 21, 2021

Saint Luke’s Innovation Week Profile: Dr. James O'Keefe
James O'Keefe, MD, understood the severity of heart disease at a young age.
May. 21, 2021

KCTV: Saint Luke's North-Smithville Donates Care Van to Local Family in Need
Saint Luke's North-Smithville donated a care van to a Smithville family whose son was in a tragic accident and is left with a significant brain injury. 
May. 21, 2021

Saint Luke’s Innovation Week Profile: Dr. Janakiraman Subramanian
Dr. Subramanian's passion and commitment to his patients was the driving force behind his involvement in creating Saint Luke's precision oncology program.
May. 20, 2021

Health News You Can Use: How Saint Luke's Research is Changing Patient Care
Actively involved in more than 100 clinical trials aimed to improve patient care, Saint Luke's Research changes lives.
May. 20, 2021

After Diagnosed with Deadly Form of Breast Cancer, Woman Sees Extraordinary Results with Clinical Trial
When Maribeth Kammert first learned she had cancer in 2015, her world came to a stop. It was early stage breast cancer.
May. 20, 2021

Endocrine Today: Diabetes drugs now ‘pillars of care’ for heart failure
Heart failure and type 2 diabetes are exquisitely intertwined.
May. 19, 2021

EXPLORER-HCM Trial shows dramatic improvements in patients with common genetic heart condition, comes after decades of no new treatments
Saint Luke’s Mid America Heart Institute announced the results of a clinical trial that will impact patient care and improve quality of life for patients suffering from the most common genetic heart condition.
May. 19, 2021

Saint Luke’s Innovation Week Profile: Dr. Anna Grodzinsky
Since Dr. Anna Grodzinsky was a toddler, she has dreamt of being a doctor, and she can’t imagine herself doing anything else.